New Jersey Institute of Technology

Digital Commons @ NJIT
Theses

Electronic Theses and Dissertations

5-31-1989

Study of an analytical method for benzo(a)pyrene metabolites in
human urine
Zheng Ouyang
New Jersey Institute of Technology

Follow this and additional works at: https://digitalcommons.njit.edu/theses
Part of the Environmental Sciences Commons, and the Toxicology Commons

Recommended Citation
Ouyang, Zheng, "Study of an analytical method for benzo(a)pyrene metabolites in human urine" (1989).
Theses. 1940.
https://digitalcommons.njit.edu/theses/1940

This Thesis is brought to you for free and open access by the Electronic Theses and Dissertations at Digital
Commons @ NJIT. It has been accepted for inclusion in Theses by an authorized administrator of Digital Commons
@ NJIT. For more information, please contact digitalcommons@njit.edu.

Copyright Warning & Restrictions
The copyright law of the United States (Title 17, United
States Code) governs the making of photocopies or other
reproductions of copyrighted material.
Under certain conditions specified in the law, libraries and
archives are authorized to furnish a photocopy or other
reproduction. One of these specified conditions is that the
photocopy or reproduction is not to be “used for any
purpose other than private study, scholarship, or research.”
If a, user makes a request for, or later uses, a photocopy or
reproduction for purposes in excess of “fair use” that user
may be liable for copyright infringement,
This institution reserves the right to refuse to accept a
copying order if, in its judgment, fulfillment of the order
would involve violation of copyright law.
Please Note: The author retains the copyright while the
New Jersey Institute of Technology reserves the right to
distribute this thesis or dissertation
Printing note: If you do not wish to print this page, then select
“Pages from: first page # to: last page #” on the print dialog screen

The Van Houten library has removed some of the
personal information and all signatures from the
approval page and biographical sketches of theses
and dissertations in order to protect the identity of
NJIT graduates and faculty.

ABSTRACT

Title of Thesis: STUDY OF AN ANALYTICAL METHOD FOR
BENZO(A)PYRENE METABOLITES IN HUMAN URINE
Zheng Ouyang, Master of Science in Environmental Science,
1989
Thesis directed by:

Dr. Arthur Greenberg
Professor of Chemistry
Department of Chemical Engineering,
Chemistry and Environmental Science

A method developed by Becher and Bjorseth for analysis of
PAH metabolites in urine was employed to investigate human
exposure to benzo(a)pyrene (BaP) - an ubiquitous environmental
carcinogen. Preliminary results are presented showing the
relationship between exposure to BaP and urinary elimination.
Although the correlation between the two variables is not
statistically significant, there appears to be a positive
association with selected exposure varibles such as smoking.

The identification of an association may establish urinary
BaP as a marker of exposure.
However, detailed study of the analytical procedure
indicated that recoveries with this method were as low as 38% for the total procedure and uncertainties in the urinary
BaP determination are likely to be high due to the low
recoveries of the method. Iodine formed during the reduction
reaction was found to be responsible for the low recovery of
BaP and attempts were made to improve recoveries. The chemical
treatment of the sample was modified to include red phosphorus
which is believed to quench free iodine and prevent its
reaction with the parent BaP. Pyrene and pyrene metabolites
had acceptable recoveries with the Becher/Bjorseth procedure.

These improved detection techniques were developed to make
these compounds usful as biomarkers for assessment of
environmental human exposure to polycyclic aromatic
hydrocarbons.
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CHAPTER 1. INTRODUCTION
Polynuclear Aromatic Hydrocarbons (PAHs) are substances
composed of two or more fused benzene rings. The most commonly
studied PAH found in the environment include anthracene,
benzo(a)pyrene (BaP), benz(a)anthracene, fluoranthene,
indeno(1,2,3-cd)pyrene, phenanthrene, perylene, and pyrene.
Many other PAH have also been reported112.
PAH are of concern in the environment not only because
they are ubiquitous contaminants but also many, particularly
BaP, are well-documented carcinogens (Figure 1 shows
structures of 12 carcinogenic PAH). Studies of occupational
hazards related to coal tar pitch volatiles in general and
PAH in particular have a long history. The association of
these compounds with the development of cancer has been
recognized for more than 200 years -'2.

Analytical

studies show that PAH appear in a large number of
industrial processes,

mainly due to high temperature

treatment of coal tar and pitch as well as incomplete
combustion or pyrolysis of organic marterial in general.
Furthermore, biological and toxicological studies show that
many PAH compounds exhibit carcinogenic effects in
experimental animals. By 1976, more than 30 PAH compounds
and several hundred PAH derivatives were reported to have
carcinogenic effects1-3, making PAH the largest class of
chemical carcinogens known today.

1

In order to assess the nature of PAH hazards to humans,
most analytical investigations have been concentrated on
samples from the atmosphere, automobile exhausts, cigarette
smoke potable water and human food.

Table 1 presents

estimates of human exposure to benzo(a)pyrene.

TABLE 1 Estimation of Daily Human Exposure to Benzo(a)pyrenea
: 1- 3
: 2-16
<0.5
: 0.05
< 50 ng/1
: 0.05
Water
Air pollution 0-30 ng/m3 : 0.45
Smoking 20 cigarettes
: 0.4
Food

Daily intake

ug
ug
ug
ug
ug
ug
ug

: 0.5-16 ug

a. See reference 4 and sources cited therein.

Air sampling is of limited value since it dose not measure
human uptake. Biological monitoring has been successfully
used to obtain information on the uptake of hazardous
chemicals in the bodies of exposure workers, and to evaluate
the relationship to airborne levels5-7.
The research described in this thesis deals with the
study of benzo(a)pyrene in human urine and examination of
the method of assay to develop a representive indicator of
the burden of exposure population to PAH.
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1.1 OCCURRENCE OF BENZO(a)PYRENE IN THE ENVIRONMENT

PAH are primarily products of the incomplete combustion
of organic materials such as forest fires or the burning of
fossil fuels. As is to be expected from such commonly
available source materials, PAH are ubiquitous in the
environment, with higher concentrations reported near urban
and industrial areas. Table 2 lists benzo(a)pyrene concentrations in the atmospheres of some cities in the United
States.

Table 2 BaP in The Atmosphere of Some Cities in U. S • a
CITY

YEAR CONCENTRATION(ng/m3)

100 large urban communities

1958-1959
1962

6.6
5

32 large urban stations

1966-1967
1968
1969
1970

3.3
2.7
2.9
2

Los Angeles

1971-1972

New York City

1979

1.1, 0.5, 3.5, 0.03
3.0-4.4

a. Source: Sawicki(1976)8.
PAH can be formed by thermal decomposition of any organic
materials containing carbon and hydrogen. Important

4

industrial sources of PAH include coal gasification and
liquification processes, combustion of fossil fuels(gasoline,
kerosene, coal, natural gas, diesel fuel), waste incineration,
automobile emissions as well as production of coke, carbon
black, coal tar pitch, asphalt and petroleum cracking. Other
sources of PAH which may be important in terms of human
exposure are foods and cigarette smoking.

1.2. POTENTIAL ROUTES OF RELEASE TO THE ENVIRONMENT
a. To The Atmosphere
The formation of PAH compounds during the incomplete
combustion of organic matter represents the major source of
such compounds in the atmosphere. The principal sources of
PAH in the atmosphere are: (a) Coal and oil fired power
stations. (b) Domestic heating.

(c)

Miscellaneous

industrial processes. (d)Automobile emissions. (e)Cigarette
smoke, and (f) Forest fires and volcanic activity. From
these sources, PAH will be released directly into the
atmosphere.
b. To Aquatic Systems
PAH gain entry to aquatic systems through several routes,
including precipitation and fallout from the atmosphere,
wastewater discharges (residential and industrial), runoff
from asphalt-covered surfaces(e.g. roads), and oil spills.

5

Waste effluents of certain industrial processes, for
example electrolytic reduction of magnesium and ferro alloy
smelting, provide a direct route of entry for PAH to
aquatic ecosystems.

1.3 HUMAN INTAKE, DISTRIBUTION, AND EXCRETION OP PAH

The intake of PAH, their distribution in the organism, and
their excretion are dependent on numerous physiological,
physical, and chemical factors which have still not been
sufficiently elucidated. Nevertheless, it is possible to
make limited assumptions based on the results of animal
studies conducted with several PAH, particularly BaP, a
well-known animal carcinogen.
PAH, once adsorbed, becomes localized in a wide variety
of body tissues . The distribution of radioactivity derived
from 14C-BaP in the rat and mouse was determined following
subcutaneoous, intravenous, and intratracheal administration.10

6

Table 3 DISTRIBUTION AND ELIMINATION OF RADIOACTIVITY
14 C-BaP

AFTER INTRATRACHEAL INSTILLATION OF
INTO RATSa

% Of administered dose after:
Site

1 hr

Feces

0

28.0

Urine

0

1.2

Stomach

0

0

37.0

11.1

Intestine

24 hr

Kidney

0

2.4

Liver

1.3

4.3

43.2

38.6

lung
Other organs
% Recovered

0.08

0.43

81.58

86.03

a. Dose: 25 ug 14C-BaP in 0.3 ml H2O.
Adapted from Kotin, P., Falk, H.L., and Busser, R., J.Natl.
Cancer Inst., 23, 541, 1959.

The pattern of distribution was found to be similar in all
cases, except for high local pulmonary concentrations
following intratracheal instillation (Table 3). Concentrations
of BaP-derived radioactivity in the liver reached a maximum

7

within only 10 min after injection and represented 12% of
the total dose. Radioactivity in the liver was reduced to 1
to 3% of the administered dose within 24 hr. Similarly,
maximum blood levels of BaP following i.v. injection were
reached very quickly, and radioactivity became barely
detectable after 10 min. Animal tissue localization of BaP
and/or its metabolites occurred in the spleen, kidney, lung,
and stomach; maximum radioactivity derived from labeled BaP
was recovered in the bile and feces. Levels of radioactivity
in fat, skin, and muscle were not determined, nor was the
amount of unchanged BaP measured in any tissue. Bock and
Dao (1961)11 showed that relative to other tissues,
unmetabolized BaP was located extensively in the mammary
gland and general body fat after a single feeding of the
carcinogen(10-30 mg). This accumulation of BaP was greater
than that resulting from administration of 3-methylchlolanthrene, 7,12-dimethylbenz(a)anthracene, or phenanthrene.
In all cases, the level of carcinogens detected in the
tissue was directly related to the dose administered, and
was dependent upon the use of a lipid vehicle.
In summary, the results of the studies indicate the
following:
a. Detectable levels of PAH and/or PAH metabolites can be
observed in most internal organs from minutes to hours
after administration.
8

b. Mammary and other fatty tissues are significant storage
depots where PAH may accumulate and be slowly released.
c. The gut contains relatively high levels of PAH and/or
PAH metabolites as a result of hepatobiliary excretion
or of the ingestion of particulate PAH following
mucociliary clearance after inhalation.
Hepatobiliary excretion and

elimination through the

feces is the major route by which PAH are removed from the
body. Kotin et al. 10 observed that 4 to 12% of the
subcutaneously injected dose of BaP was eliminated in the
urine of mice within 6 days after injection, while 70% to
75% of the dose was recovered in the feces. Less than 1%
of BaP recovered in the bile was unmetabolized. Camus et
al 12 determined fecal excretion rates of BaP in two
different strains of mice following i.p. injection of BaP.
The cumulative excretion of BaP in feces followed an
exponential curve with half-lives of 1.2 and 0.6 days for
the two different strains. The majority of metabolites in
the urine appeared as highly water -soluble conjugates. For
example, the relative amount of unmetabolized BaP found in
urine from mice following i.p. injection of 14C-labeled BaP
was as low as 0.7% of the total amount excreted in
urine.13 After enzymatic deconjugation, various oxidized
BaP metabolites could be identified.

9

1.4

METABOLISM AND ACTIVATION OF PAH

PAH are among the chemical carcinogens which are not
chemically highly reactive themselves, but exert their
carcinogenic activity through metabolites which are
sufficiently reactive to modify cellular macromolecules
such as nucleic acids (DNA, RNA) and proteins.14
Metabolism is dominated by oxidation through the
microsomal mixed-function oxidase (MFO) system, often
termed aryl hydrocarbon hydroxylase (AHH), which is most
abundant in the liver. This enzyme system has been studied
extensively and is the subject of several reviews.15,16
While it is known that this enzyme complex is involved with
detoxification of xenobiotics in conjunction with various
P-450-type cytochromes, it is apparent that this system is
also responsible for the metabolism of polycyclic
hydrocarbons to their active species (Figure 2).
The first step

in this metabolic activation of PAH,

catalyzed by the cytochrome P-450 monooxygenase system,
gives rise to epoxide and phenolic groups in different
positions on the polycyclic ring system.17 A second
microsomal enzyme, epoxide hydrolase (EH), converts
epoxides into vicinal diols.
Information on EH has been summarized recently,18 and
its importance in the formation of three known dihydrodiols
10

FIGURE 2' Enzymatic pathways involved in the activation and
• detoxification of PAIL
Source:

ref. 13
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of BaP has been demonstrated.19 Dihydrodiols may be
further oxidized by the MFO system to dihydrodiol
epoxides.20 There is now considerable evidence that a
particular structural class of diol-epoxides, namely the
bay-region dihydrodiol-epoxides, operate as the ultimate
carcinogenic form of PAH, which react easily with cellular
macromolecules, in particular DNA.21,22
Other reactions involved in the metabolism of PAH are
enzymatic conjugations of the oxygenated intermediates to
glucoronic acid, sulfate, and glutathione.23 These watersoluble conjugates are readily removed from the organism
through bile, feces, and urine, and have been generally
viewed as detoxification products.
Identification of metabolites has been performed for some
PAH, with BaP being the compound studied most extensively.
The metabolism of BaP is outlined in Figure 3. BaP
metabolites found in microsomal incubation are 1-hydroxyBaP, 3-hydroxy-BaP, 6-hydroxy-BaP, 7-hydroxy-BaP, and 9hydroxy-BaP. The BaP-4,5-epoxides have been isolated and
identified as precursors of the BaP-4,5-diol. Other studies
indicate that epoxides are precursors of the 7,8-diol and
9,10-diol as well. There have been no intermediates
isolated as phenol precursors, although recent evidence
using deuterium labeling suggests that at least a portion
of 3-OH-BaP is derived from an intermediate 2,3-

12

FIGURE

3 Composite of metabolic products of benzo(s)pyrene.

Source: ref. 13

epoxide.24 In addition to the hydroxylated metabolites,
1,6-, 3,6-, and 6,12-BaP-quinones have been identified.25
These are produced enzymatically by microsomes and
nonenzymatically by air oxidation of phenols.26
Further oxidation of 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene
by the MFO system leads to the formation of the highly
reactive and probably ultimate carcinogenic metabolites,
the isomeric 7,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene in which the epoxy ring is adjacent to the
"bay" of the hydrocarbon.27 These diol-epoxides react
rapidly by electrophilic attack with cellular macromolecules.
Adduct formation has been observed with DNA, RNA, and
proteins.22,28
The relative proportions of metabolites have been
estimated by many authors. This is usually done using
tritium-labelled BaP, although there is some error due to
detritiation during metabolism.

The proportions vary

according to whether and how the enzyme system was induced,
and consequently which form of cytochrome P450 is present.
The products of metabolism of the known forms of P450 in
rat liver were determined by Wilson et al (1984);29 some
data are given (% of total metabolites) in Table 4.
P450PCN is a form of low activity, induced by pregnenolone16a-carbonitrile. Note that this and the phenobarbitoneinduced forms produced mainly BaP-4,5-dihydrodiol in

14

comparable proportions.

Table 4 Products of metabolism of P450 in rat liver24

Dihydrodiols
Form

4,5-

Uninduced

18

9

11

P450b

52

1

P450c

17

P450PCN

55

7,8-

Diones

9,10-

1,6-

Phenols

3,6-

3-

9-

8

24

22

8

2

6

7

30

3

15

33

8

12

13

2

0

0

0

0

45

0

1.5 CANCER IN WORKERS EXPOSED TO PAH.
Since it has been known for many years that coal tar, as
well as some isolated PAH are carcinogens in experimental
animals, many investigators have studied the cancer
frequency of workers known to be exposed to coal tar or
coal tar pitch volatiles ( CTPV ) in relatively high
concentrations. The International Agency for Research on
Cancer (IARC, 1983) stated that there is sufficient evidence
to indicate that 11 PAH are carcinogenic to experimental
animals3° ( Table 5 ).

15

TABLE 5. PAH For Which Sufficient Evidence Is Known That
These Compounds Are Carcinogenic To Experimental
Animals

Chemical Name

Chem. Abstr. Services Reg No.

benz(a)anthracene

56-55-3

benzo(b)fluoranthene

205-99-2

benzo(j)fluoranthene

205-82-3

benzo(k)fluoranthene

207-08-9

benzo(a)pyrene

50-32-8

dibenzo(a,h)pyrene

53-70-3

dibenzo(a,e)pyrene

192-65-4

dibenzo(a,h)pyrene

189-64-0

dibenzo(a,h)pyrene

189-55-9

dibenzo(a,l)pyrene

191-30-0

indeno(1,2,3-cd)pyrene

193-39-5

Source: IARC(1983)30
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1.6 BACKGROUND AND OBJECTIVE OF THE THESIS
Since 1987, a Total Human Environmental Exposure Study
(THEES) has been conducted to investigate multimedia
exposure to the ubiquitous environmental carcinogen,
benzo(a)pyrene. This study represents the State of New
Jersey's primary research effort in the rapidly growing
field of total human exposure monitoring.31
As a substudy of THEES, the relationship between exposure
to benzo(a)pyrene and biological levels, as measured BaP
metabolites in human urine, is being modeled. As mentioned
earlier, BaP was eliminated mainly through feces (the
excreted amount of BaP via feces is five to seven fold of
that of BaP via urine). However, urine was chosen as a
biomonitoring specimen in this study due to the reasons of
(a) non-invasive (urine was much easier to collect from
volunteers). (b) feces was more difficult to assay and (c)
there are a lot of data about BaP metabolites in urine. The
results of BaP metabolites analysis will be used to verify
a human compartmental model that was developed based on
animal pharmacokinetic studies in the literature.10-12
The method employed to analyze BaP in urine samples is
based on a procedure developed by Becher and Bjorseth.32
The procedure was investigated. Discoveries show that it
was necessary to modify the procedure in order to obtain
resonable and consistent yields.
17
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CHAPTER 2. PAH BIOLOGICAL MONITORING PROFILES

Air monitoring of PAH only quantifies the respiratory
intake (external dose). PAH may be absorbed not only in the
lungs, but also in the gastrointestinal tract and through
the skin. The monitoring of PAH or their metabolites in
body fluids reflects the total uptake (internal dose).
Biological monitoring of PAH may thus be useful in order to
make an accurate estimation of the individual dose. It can
help industrial hygeinists to identify highly exposed
workers. Moreover, unbiased estimations of exposure to PAH
are needed to increase the power of epidemiologic studies.

2.1 Conditions For The Development Of A Method Of
Biological Monitoring.

Knowledge of Toxicokinetics of PAH. - Knowledge of the
metabolism of benzo(a)pyrene, one of the PAH, is extensive.
In many studies on chemical carcinogenesis, BaP has been
used as a model substrate. Excellent metabolism reviews
have been presented.1,2 The intermediary epoxide-PAH and
dihydrodiol-epoxide-PAH are supposed to be crucial metabolites
in the carcinogenesis of PAH., The interindividual variation
of the metabolism of PAH in cultured human tissues and cells
is great.3 The excretion of PAH-metabolites has been studied
in experimental animals. After inhalation of BaP by rats most
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of the excreted metabolites (85-95%) were found in the
feces.4 f 5 A minor part was excreted in urine.

Validation Of A Biological Test - When the basic
toxicological investigations have suggested a useful
biological parameter, other demands must be met before
applying this test in preventive industrial health care.

The demands of a valid biological parameter are:6
- sufficiently sensitive
(low detection limit, high accuracy and high
reproducibility)
- Sufficiently specific
(few interfering factors)
- Sufficiently stable to allow storage of samples
- Non-time consuming analysis by a not overly sophisticated
technique
- When these demands are met a normal value among nonexposure referents must be determined.

2.2 View of Biological Monitoring
Biological monitoring is primarily an activity where
repetitive measurements of toxic chemicals in biological
specimens are used to assess the exposure levels of
individual workers and of groups of workers. Up to now three
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ways of biological monitoring of PAH have been proposed:
(a) the urinary mutagenicity assay, (b) determination of
the unmetabolized and metabolized BaP in body fluids and
(c) reduction of urinary PAH-metabolites to their parent
compounds.
a. The urinary mutagenicity assay has been applied for the
detection of exposure to PAH. Volunteers and dermatological
patients excreted mutagenic urine after application of
crude coal tar to the skin.7'8 The determination of mutagenic
metabolites in urine with the aid of the Ames-assay was
proposed to detect occupational exposure to mutagenic PAH.
Kriebel et al.9 reported a higher mutagenic activity in
urine of non-smoking, coke plant workers than in the nonsmoking control group. Several other studies have failed to
detect enhanced excretion of mutagens of the urine of
workers exposed to PAH.10-12

However, a dose-dependent

excretion of mutagens in the urine of rats after exposure to
benzo(a)pyrene BaP was shown.13 The poor sensitivity of
the urinary mutagenicity assay to detect exposure to PAH
seems to be the cause of the negative results in human urine.
b. Other reports deal with the measurement of unmetabolized
BaP as an indicator of PAH. Hutcheon et a1,14 using a radioimmunoassay (RIA), found a higher level of BaP in the
plasmas of occupants of an urban-industrial area compared
to an outer suburban area (1.62 vs. 0.04 ug/l). Low
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concentrations of fluorescent material, presumably
unmetabolized PAH, have been observed in urine samples from
tobacco smokers and nonsmokers (Table 6). Maly15 used acid
hydrolysis of the urine samples petroleum extraction, and
paper chromatography for the semiquantitative determination
of dibenzo(a,l)pyrene. Repetto and Martinez16 separated BaP
from methylenechloride extracts of urine samples by
preparative colunm chromatography on silica, and
quantitated BaP by spectrofluorimetry. Szyja found high
amounts of unmetabolized BaP in urine samples of topside
coke oven workers, collected after 6 hr of work ( Table 6 ).
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Table 6 CONCENTRATION OP PAH IN HUMAN URINE SAMPLES

PAH
Dibenzo(a,l)pyrene

BaP

BaP

BaP

Subjects

No. of

Concentration

samples

(mean in ug/l) Ref.

Active smoker

1

1.1

15

Passive smoker

1

0.3

15

Active smoker
(morning)

8

0.17

16

Active smoker
(evening)

7

0.34

16

Passive smoker
(morning)

1

0.15

16

Passive smoker
(evening)

1

0.23

16

Nonexposed
(morning)

1

0.01

16

Nonexposed
(evening)

1

0.06

16

After 6 hr work

19

4.67

17

After 18 hr rest

13

2.1

17

After 48 hr rest

8

1.6

17

451

0.690

18

35

0.445

18

Topside coke oven
worker

Persons from
urban/industrial
area
Persons from
rural area
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(continues)
No. Concentration
PAH

Subjects

Samples (Mean in ug/l) ref.

Benz(a)Persons from
anthracene urban/industrial
area

437

0.701

18

34

0.489

18

Smokers

7

68.2b

28

Nonsmokers

4

79.3b

28

6

45.4b

28

4

13.2b

28

Persons from
rural area
Sum of 11
prominent
PAHa

Aluminum workers

Control
Smokers
Nonsmokers

a. Sum of PAH and PAH metabolites determined by reversedmetabolism method.
b. Results converted from ug PAH/mmol creatinine using an
average excretion of 12 mmol creatinine per 1 urine.
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The urinary PAH levels were significantly lower after
18- and 48-hr rests. Michels and Einbrodt18 determined
the concentrations of BaP and benz(a)anthracene (BaA) in
more than 480 urine samples of randomly selected persons
from a highly industrialized area, and from a rural area as
reference. The excretion of both BaP and BaA was found to
be significantly higher in the polluted area compared to
the reference area (Table 6). No differences, however, were
observed between urines from smokers and nonsmokers. Song
et al 19 reported a method for the determination of BaP
in urine. Urinary BaP levels in operators working on the
top of the coke oven were higher than those in operators
working at the side of the coke-oven (AM=0.063 and 0.026
ug/1 respectively). BaP was not found in urine samples of
non-exposed workers ( < 0.010 ug/l).20 The presence of
BaP in the body as reported by Hutcheon,14 Song,19 Szyja17
and Michels & Einbrodt18 may be overestimated by
interferences of hydroxylated metabolites, due either to
the known cross-reactivity of the RIA for 3-0H-BaP21 or to
separation techniques with poor discrimination.
In the studies described above, only the unmetabolized
part of the PAH excreted in urine was determined. However,
as mentioned earlier, PAH are metabolized to a great extent
to polar, water-soluble metabolites both in vitro and in
vivo. Thus, an alternative approach has been suggested by
Keimig et a122 to analyze urine for metabolites of specific
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PAH compounds that are consistently prominent in
environmental samples. They have identified 1-hydroxypyrene
as a major metabolite in the urine of pigs and propose this
metabolite for monitoring PAH-exposed workers. Later,
Jongeneelen et a128 isolated 1-hydroxypyrene from human urine
by enzymatic hydrolysis, HPLC separation with fluorimetric
detection. A similar method was used again by Jongeneelen
et a128 to

analysis 3-hydroxybenz(a)anthracene and 3-

hydroxybenzo(a)pyrene in human urine. An HPLC method for
measuring BaP and phenolic BaP-metabolites in urine is
proposed by Mathieu et a1.25 They did not report measurements
in urine samples from exposed individuals. Grimmer et a1.26
separated phenanthrene and five isomeric hydroxyphenanthrenes
in urines of man and rat by gas chromatography after acidic
hydrolysis.
Although the methods mentioned above are sensitive and
specific, their practical applications for estimation of
human exposure to BaP are still limited. Moreover, as
mentioned early, BaP is transformed in the body to more than
twenty metabolites (IARC 1983)27 and the proportions of
BaP metabolites in human urine are still unclear. Thus,
there are still many uncertainties in using any of these
metabolites to indicate the burden of the body.
c. An interesting monitoring method was developed by
Becher and Bjorseth.28 They have described a method to
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determine multiple PAH compounds in urine specimens based
on the reduction of excreted, oxidized PAH metabolites
back to the parent hydrocarbons. The analytical procedure
included extraction of PAH and PAH metabolites from urine
using cartridges containing C18 modified silica, reduction
of metabolites to PAH by refluxing hydriodic acid
("reversed metabolism"), and subsequent analysis of 11
prominent PAH by HPLC with fluorimetric detection. This
analytical procedure has been the subject of our detailed
investigation as described later in this thesis.
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CHAPTER 3 SAMPLE COLLECTION
3.1 Field Study-Location
The THEES project is being conducted in Phillipsburg,
a municipality of approximately 16,500, in a rural section
of New Jersey. A major smoke stack industry in the center of
town, a grey iron pipe manufacturing company, has existed
since 1856. The other major local outdoor air pollution
sources are space heating and motor vehicle traffic. The
northern portion of the city is situated adjacent to
primary truck routes. The center of Phillipsburg and the
pipe manufacturing plant are located in a Delaware River
valley.
A previous two year air sampling study for airborne BaP
in New Jersey showed that, of twenty seven monitoring
sites, Phillipsburg had the highest BaP concentration for a
twenty-four hour sample (7.8 ng/m3) and the second highest
mean concentration (0.8 ng/m3)1. In contrast, Phillipsburg
ranked only fourteenth in maximum non-polar extractable
organics concentration, suggestion enrichment of BaP in the
area.
Central heating for homes is primarily #2 oil while room
space heating includes kerosene and coal burning stoves.
The major water purveyor for the area in the Garden State
Water Company. The water supply comes from three wells in
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town and two wells that are located approximately 1.6 km
away2.

3.2 Population and Home Characteristics2
The population for this total exposure study was not
meant to be a statistically selected subgroup or
representative sample of the types of people living in the
Phillipsburg area. The selection of a limited number of
participants was based upon the desire to examine the daily
contributions of indoor and local outdoor air pollution and
other media to human exposure in detail over the course of
two weeks. The study participants were selected from
respondents to a mail solicitation made to individuals
living in the area surrounding the plant, and control areas
to the north and south of the plant.
The study design called for a total of ten homes as the
indoor sites, eight near the foundry and two outdoor air
controls. The location of each home is shown in figure 4.
Homes 1-3 are located in the valley near the plant Homes
4, 5 and 6 are in an area near the plant, but up a slight
grade across the railroad tracks. Fugitive emissions from
the plant may be funneled to these homes through a train
trestle underpass. Homes 7 and 8 are located near outdoor
site #2. Homes 9 and 10 are located across Route 22
approximately 2 km to the north of the foundry, near
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outdoor site #4, on a ridge a kilometer away from the
valley floor.
The homes and the study population had some
characteristics which were typical to all, and others which
were unique to individual homes. Examples of major
similarities are: 1) all homes are over fifty years old; 2)
nine homes are of wood construction; 3) no homes have an
attached garage; 4) no homes have a fireplace; and 5) all
homes are less than 5m from the street. Three of the homes
had at least one smoker in residence, and six of the homes
had children living at home. The ages of the adult
participants ranged from 26 through 78, and ages for the
children ranged from 6 months through 17 yrs.
Seven homes used oil, two used gas and one used a coal
stove for central heating. Home 10 (with the coal stove),
was one of the two selected away from the foundry as a
control for the outdoor BaP sources. For the winter,
however, the coal stove created an indoor source
environment which would be used to examine the influence of
indoor coal combustion on indoor air quality. Indoor
combution source at each THEES home was listed at table 7.
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Figure 4 THE PHILLIPSBURG AREA AND SITE LOCATIONS

41

Table 7 INDOOR COMBUSTION SOURCES LOCATED EACH TREES HOME
Home ID

Types of Sources

1

Gas Cooking Range and Oven
Toaster
Oil Central Heat

2

Oil Central Heat
Electric Range & Oven
Microwave Oven
1 Smoker in residence

3

Oil Central Heat
Kerosene heater(in living room or
kitchen)
Electric Range & Oven
2 Smokers in residence

4

Oil Central Heat
Kerosene heater (in dining room or
hall)
Electric heater
Gas Range & Oven
Microwave Oven

5

Electric Range & Oven
Microwave Oven
Oil Central Heat

6

Gas Central Heat
Kerosene Space Heater
Electric Range & Oven
Toaster
Gas Central Heat
Electric Range & Oven
Microwave

8

Oil Central Heat
Gas Range & Oven
Toaster Oven
Microwave Oven

9

Oil Central Heat
Gas Range & Oven
1 Smoker in residence

10

Oil Central Heat (rarely used)
Coal Central Heat (primarily & in
living room)
Kerostene Heater (in kitchen)
Microwave Ovn, Gas Range & Oven

Source: ref. 2
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3.3 Sampling methodology
Ideally 24-hr urine would be collected to correlate with
the 24-hour exposure samples. This strategy would minimize
any effects due to diurnal variations in urinary
elimination3 and provide sample volume for analysis 24-hour
collections were not practical for the 14-day study due to
participant compliance and storage limitations. The urine
sampling strategy employed collected as many voids in a day
as possible so that a daily composite sample would be as
representative as possible of that day's total elimination.
Participants were requested to collect and record the
time of all voids while at home. In addition, participants
were asked to record the time of their last void before
returning home in the afternoon. This strategy resulted in
the collection of samples covering from 8 to 22 hour/day in
duration, with the weekend samples of longest duration.
Each void was collected separately in a wide-mouthed 220 ml
clear high-density polyethylene cup with a snap on cap.
The 220 ml cup was placed in a opaque cylindrical container
which was used to protect the samples from light. It also
had an aesthetic advantage, affording the participants some
privacy when the samples were picked up each day. Samples
were stored frozen and later aggregated in the lab
according to the 24-hour sample period of the diet and
personal air exposure samples. The urine samples were
aggregated to lag the exposure samples by 2 hours to
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compensate for gastric emptying, absorption, etc. The
composite samples were stored protected from light in 550
ml amber glass comtainers at -20 C. Study by Jongeneelen et
al(1987)4 indicated that this storing method is reliable.
The urinary sampling is summarized in Table I. The
duration of the sample was measured from the time of the
void prior to the first collected sample through the
collection of the last void.

Table 8.

SUMMARY OF THEES PHASE II PRELIMINARY URINE
SAMPLING AVERAGE DAILY VALUES

PID

Sex

001

M

21.8

6

1355

011

F

22.5

4

769

031

F

17.2

5

785

041

F

10.8

2

242

042

F

14.6

4

561

051

F

14.1

4

610

052

M

11.1

4

607

061

F

15.6

4

545

062

M

13.8

3

439

081

F

14.8

3

825

Sample
Duration(hr)

Number of
Samples
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Total
Volume(m1)
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CHAPTER 4 DETERMINATION OF BENZO(a)PYRENE METABOLITES
IN HUMAN URINE
TLC has been widely used for the separation of PAH due to
its simplicity of operation, its rapidness, and the
possibility of facile sample recovery for further
identification of the separated PAH. The

principal

disadvantage lies in the possibility of degradation of
sensitive PAH adsorbed onto the active surface of the
stationary phase.1/2 However, Inscoe3 reported that
recoveries from cellulose acetate plates average around 95%
and are much higher than from alumina plates where
photochemical oxidation reactions take place during
chromatography.
The analytical procedure is based on the reduction of
excreted, oxidized metabolites of BaP back to the parent
hydrocarbons. After hydrolysis by hydrochloric acid, BaP
and its metabolites in the urine sample were extracted by
conmercial preparetive cartridges containing C18-modified
silica and reduction of metabolites to parent BaP by
refluxing hydriodic acid. Subsequente analysis was by thin
layer chromatography (TLC) using selective and sensitive
fluorescence detection. This method was modified from the
Becher and Bjorseth report.4 In turn, the reduction reaction
of hydriodic acid is based on research by Konieczny and
Harvey.5 During the analysis we realized that the recovery

46

of Becher/Bjorseth procedure was extremely low and we had a
detail study of this procedure which is present at Chapter 5.
Results presented in this chapter are not corrected for
recovery and except indicated are without red phosphorus.
4.1 Chemicals and Apparatus
Benzo(a)pyrene(99%), anthraquinone(97%), anthracene(97%),
and pyrene(99%) were purchased from Aldrich Chemical Co..
3-hydroxy-BaP,

9-benzo(a)pyrenyl-b-d-glucopyranosiduronic

acid were purchased from Midwest Research Institute (MRI).
BaP-3,6-dione, BaP-4,5-dione, BaP-7,8-dione, BaP-6,12-dione
were obtained from IIT Reseach Institute. 1-hydroxypyrene,
2-hydroxypyrene, 4-hydroxypyrene, pyrene-1,6-quinone and
pyrene-1,8-quinone were kindly provided by Dr. Joseph Rice
Dept. of Pharmaceutical Chemistry School of Pharmacy
Rutgers University, Piscataway, N.J.
Hydriodic acid (47-51%), methylene chloride, methanol
(HPLC grade) and anhydrous alcohol were purchased from J.T.
Baker Chemical Co..Hydriodic acid (65%), acetic acid(99.5%)
and potassium disulfate were purchased from Fluka Co..
Phosphorus red (amorphous) was obtained from Fisher
Scientific Co.. Hydrochloric acid and sodium sulfate
anhydrous were purchased from Mallinckrodt Co..
The precoated thin layer chromatography plates(20x20 250
microns and 20% acetylated cellulose) were purchased from
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Analtch Co. an AIS TLC multispotter was used for TLC plate
spotting and fluorescence detection was performed with a
Perkin-Elmer MFP-44B Fluorescence Spectrophotometer, IBM
personal computer with non-linear correction program (which
fit a least square parabola having the form Y = A° .4_ A1X
+A2X2 ) was used to calculate benzo(a)Pyrene concentrations.
4.2 Procedure of Urine Analysis
100 ml human urine samples were adjusted to pH=2 with
concentrated hydrochloric acid and allowed to stand for 30
min. at room temperature.
A sep-pak C18 cartridge (Water Associates) was used for
separation of the metabolites of BaP. After priming the
cartridge with 5 ml methanol followed by 10 ml water, the
hydrolyzed sample was passed through the cartridge at a
rate of approximately 10 ml/min. Retained solutes were
eluted using 5 ml methanol and 5 ml cyclohexane and then
elutes were combined. The solvent was evaporated under an
air flow and residue refluxed with 1 ml 49% hydriodic acid
and 15 ml acetic acid for 24 hrs in an oil bath.
The hot solution was poured into 80 ml of 1% aqueous
potassium disulfate solution and extracted twice, first with
40 ml then with 20 ml cyclohexane. The organic phase was
washed with water and dried with anhydrous sodium sulfate.
The extract was concentrated to 1 ml with constant air flow,
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and 100 ul spotted on an acetylated cellulose thin layer
chromatography (TLC) plate. The TLC plate was developed
using 2 : 1 ethanol/dichloromethane and analyzed spectrofluorimetrically via plate scanner at 387.0 nm for
excitation, 428.6 nm for emission.
4.3 Determination Of Detection Limit
With 1 ng/ml BaP standard, different volumes of the
standard were injected on the TLC plate, then developed
under the same conditions as the urine samples and the BaP
was detected by a fluorescence spectrophotometer.
4.4 Results
Eleven adult urine samples collected daily over fourteen
days have been analysed so far. The limit of detection is
5 ng/1 (0.005 ug/l) with this procedure (Table 9). The results
of measurement in human urine are listed in Table 10 to Table
20. Data presented are not corrected for recovery.
During the preresearch period,

urine specimens were

collected from two participants (one smoker and one
nonsmoker from different families). Indoor air sampling was
conducted simultaneously. The indoor air quality and BaP
urine excretion appear to be related (Figure 5). The mean
concentration of BaP in the smoker's urine was 170 ng/1
( For total of six samples, max. 691 ng/1 and min. 8 ng/1 )
compared with 58 ng/1 (For total sevene samples, max. 262
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ng/1 and min. 6 ng/1) for the nonsmoker; concordantlly, the
mean indoor air concentrations of BaP in House no. 1 (smoker)
was 0.608 ng/m3 (n=4) compared with 0.334 ng/m3 (n=5) for
House no. 2 (nonsmoker).
BaP exposure and urinary elimination were determined
simultaneously. The methods of analysis for personal air
and food samples were described elsewhere.6'7 The data for
two participants in Phase II (#42 and #81, see Table 14, 19)
are used to model the relationship between exposure to
benzo(a)pyrene and BaP metabolite level in human urine.8 A
scatter-plot of elimination verses exposure, Figure 6
indicates all values are detectable and that there is
variability in the data. Moreover, in about 80% of the data
there appears to be emerging a pattern suggesting a positive
association between the variables i.e., elimination increased
with exposure.8
A second analysis of the BaP exposure/elimination data is
presented by comparing the fractional change in exposure
and elimination from week 1 to 2, see Figure 7. The
fractional change for both exposure and elimination was
calculated as the difference between week 1 and 2 divided
by the two week mean. Such an analysis compares relative
changes from week 1 to week 2 in exposure and elimination.
A positive association (data points in quadrantsll and III)
is indicated in 7 of 10 cases.
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Table 9. Detection Limit of BaP in TLC Separation and
Fluorescence Detection
Injection Vol. (ul)
of BaP standard (1 ng/l)

Rt (sec.)

Area

10

49

756

20

50

1312

30

50

1940

40

51

2856

50

50

3802

60

51

4587

70

51

5629

80

52

6970

90

53

7333

100

53

7549

*. The minimum integration area of the computer was set to
1000 (as measure of random noise), the limit of detection
will be three times this value (Anal. Chem. 1980, 52, 22422249).
Detection Limit: 50 ul BaP standard injected = 0.05 ng BaP.
This means that if the BaP from metabolites in 100 ml of
urine is concentrated in 1 ml and a 0.1 ml (100u1) aliquot
is analyzed, then the limit of detection for a typical 100
ml urine sample is 0.5 ng/100 ml or 5 ng/1 (0.005 ug/l).
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Table 10. ANALYTICAL RESULTS OF BaP METABOLITES IN PERSON
ID #1 URINE SAMPLES (TREES PHASE II)

Sample Number
(Day 1-15)

Results(ug/1)

Sample
Volume (ml)

1.

0.011

510

2.

N.D.

500

3.

0.017

420

4.

0.016

470

5.

0.019

490

6.

0.038

510

7.

0.016

500

8.

0.030

480

9.

0.025

490

10.

0.016

480

11.

0.028

470

12.

N.D.

460

13.

0.033

300

14.

0.013

450

15.

0.007

390

N.D.: Not detected.
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Table 11. Analytical Results of BaP Metabolites in Person
ID 1 11 Urine Samples (TREES Phase II)

Sample Number
( Day 1 - 15 )

Results ( ug/1 )

Sample Volume
( ml )

1.

N.D.

490

2.

0.007

530

3.

N.D.

500

4.

N.D.

540

5.

0.015

450

6.

N.D.

480

7.

N.D.

420

8.

0.026

490

9.

0.006

470

10.

0.023

420

11.

0.01

450

12.

0.015

500

13.

0.007

450

14.

0.005

450

15.

N. D.

N.D.: Not detected.
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Table 12. Analytical Results of BaP Metabolites in
Person ID 131 Urine Samples (TREES Phase II)

Sample Number
(Day 1-15)

Results(ug/1)

1.

0.053

250

2.

0.027

350

3.

0.043

330

4.

0.012

350

5.

0.007

370

6.

0.011

420

7.

0.020

400

8.

0.005

320

9.

0.013

350

10.

N.D.

350

11.

0.010

340

12.

0.010

420

13.

0.023

380

14.

0.007

450

15.

0.015

430

N.D.: Not detected.
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Sample Volume
( ml )

Table 13. Analytical Results of BaP metabolites in Person
ID #41 Urine Samples (TREES Phase II)

Sample Number
(Day 1 - 13)

Results ( ug/1 )

Sample Volume
( ml )

1.

0.006

390

2.

0.032

210

3.

0.010

130

4.

0.007

300

5.

0.032

150

6.

0.010

200

7.

0.017

160

8.

0.021

230

9.

0.015

290

10.

0.012

120

11.

0.006

350

12.

0.016

150

13.

0.016

240
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TABLE 14. THE RESULTS OF BaP METABOLITES IN # 42 HUMAN URINE
SAMPLES

SAMPLE
I.D.

WITH
PHOSPHORUS
( ug/1 )

1

0.28

2

0.01

3

0.11

5

0.11

7

0.38

9

0.06

10

0.05

11

0.21

14

0.03

15

0.06

N.D: Not detected.
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WITHOUT
PHOSPHORUS
( ug/1 )

N.D.

0.05

Table 15.Analytical Resultsof BaP Metabolites in Person
ID #51 Urine Samples (TREES Phase II)

Sample Number
(Day 1 - 15)

Results ( ug/1 )

Sample Volume
( ml )

1.

N.D.

480

2.

0.024

390

3.

0.028

260

4.

0.019

440

5.

0.023

450

6.

N.D.

450

7.

0.053

440

8.

0.008

9.

0.018

10.
11.

0.007

12.

N.D.

420

13.

N.D.

390

14.

0.005

390

15.

N.D.

220

N.N.: Not detected.
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Table 16. Analytical Results of BaP Metabolites in
Person ID 152 Urine Samples (TREES Phase II)

Sample Number
(Day 1 - 14)
1.

Results (ug/l)

0.015

2

Sample Volume
( ml )
450
380

a.

0.005

b.

0.007

3.

0.023

150

4.

0.010

160

6.

0.026

400

7.

0.012

250

8.

0.013

350

9.

0.016

370

10.

0.015

340

11.

0.017

400

12

0.047

340

13

0.011

300

14

0.018

400

15

0.123

330

a., b.: Duplicated analysis.
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Table 17. Analytical Results of BaP Metabolites In Person
ID # 61 Urine Samples (THEES Phase II)

Sample Number
(Day 1 - 15 )

Results ( ug/1 )

Sample Volume
( ml )

1.

0.022

280

2.

0.038

430

3.

0.010

500

4.

N.D.

490

5.

0.014

380

6.

N.D.

380

7.

N.D.

190

8.

0.024

430

9.

0.012

440

10.

0.007

330

11.

N.D.

440

12.

N.D.

380

13.

N.D.

360

14.

0.010

480

15.

N.D.

180

N.D.: Not detected.
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Table 18. Analytical Results of Bap Metabolites in
Person ID #62 Urine Samples (TREES Phase II)

Sample Number
(Day 2 - 14)

Results ( ugh

)

Sample Volume
( ml )

2.

0.088

330

3.

0.026

320

4.

0.018

450

5.

0.012

200

6.

0.019

340

7.

0.084

350

8.

0.005

240

9.

0.015

450

10.

N. D.

420

11.

N. D.

200

12.

N. D.

400

13.

0.013

350

14.

0.010

330

N.D.: Not detected.
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Table 19. Analytical Results of BaP Metabolites in # 81
Urine Samples

Sample I.D.

With Phosphorus
( ug/1)

Without Phosphorus
( ug/1 )

3

0.05

N.D.

4

0.02

0.01

5

0.03

N.D.

6

0.06

0.03

7

0.04

N.D.

8

0.01

0.01

9

0.03

0.02

11

0.21

12

0.02

13

0.10

14

0.14

N.D.

N.D.: Not detected.
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Table 20. Analytical Results of BaP Metabolites in # 92
Human Urine

Without Phosphorus
( Ug/1 )

Sample I.D.

With Phosphorus
( ug/1 )

6

0.32

7

0.02

0.006

8

0.06

0.02

9

0.04

0.01

10

0.03

N.D.

14

0.03

15

0.20

N.D.--- Not detected.
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Figure 5+ Incoor Air Exposure
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And BcP Urine Excretion

Figure 6

Scatter-plot of BaP Exposure
and Elimination.

Urinary elimination is not corrected for analytical rncoveries.
Source: ref. 6
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Figure 7 Week 1 to Week 2 Fractional Elimination
and Exposure.

Urine Analysis with Red Phosphorous

Urine Analysis without Red Phosphorous
Source: ref. 6
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CHAPTER 5 STUDY OF THE ANALYTICAL PROCEDURE

The principal benefit of the Bjorseth and Becher procedure
is that of "reversed metabolism" - recovering of metabolites
of PAH in urine in the form of their parent compounds.
The difficulties in analyzing PAH in body fluids arise from
the fact that the PAH mixture in a work environment frequently
contains as many as 100 different PAH compounds1 and each
PAH compound is transformed to a large number of metabolites .1
However, Becher and Bjorseth did not indicate the total
recovery of the procedure. Uncertainties in the urinary
BaP determination are likely to be high due to the low
recoveries of the method.

In this substudy, research investigation focused on the
following issues:
a. Checking the recovery of every step of the procedure.
b. Figuring out the influences of the chemicals utilized
(hydriodic acid, acetic acid.) on the reduction of BaP
metabolites.
c. Measuring of reduction yields of different PAH metabolites
by this procedure.
d. Examining the hydrolysis rate by hydrochloric acid.
e. Developing improved methods.
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5.1 The Recovery Yield of BaP And Its Metabolites In The
Procedure
The Becher and Bjorseth procedure was tested as shown in
Figures 8-12 and the results are achieved as follows:
a. The recovery yield of the steps at hydrochloric acid
hydrolysis and Sep-Pak cartridge chromatography is
about 30-40% for BaP.
b. The recovery yield of the step involving refluxing
with acetic acid and hydriodic acid is only about 3036% for BaP.
c. The recovery of extraction with cyclohexane (40 ml and
20 ml) is about 80% for BaP.
d. The recovery of blow down of the extracts to 1 ml with
air is greater than 90% for BaP.
e. The total recovery of the procedure for BaP is about
8%.

The hydrolysis yield of hydrochloric acid was examined
with 9-Benzo(a)pyrenyl-b-d-glucopyranosiduronic acid. The
result indicated that the hydrolysis yield is about 50%.
With the [3H]BP treated mouse urine, which was kindly
provided from Dr. Regina Santella from the Columbia
University School of Public Health, experiments have been
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applied on the procedure to check recovery of BaP metabolites
in urine. The results are compared with that of radioactivity
counts.
As Figure 13 shows, BaP was transformed to several
principale metabolites by the mouse. With Becher and Bjorseth
procedure, the recovery yield of these metabolites to BaP
is about 5 % (n= 6 see Figure 12)*, which is lower than the
result of former study2(Recovery = 8%).

5.2 The Influence of Hydriodic Acid and Acetic Acid on
the Reductive Action of BaP Standard
The affect of hydriodic acid on the recovery of BaP
standard (70 g/ml, 100 ul) was tested (Fig 9). The recovery
yield of refluxing only with glacial acetic acid is almost
99% while the recovery of refluxing with acetic acid and
hydriodic acid is 30%. The recovery of refluxing with iodine
(equal mole. to 1 ml hydriodic acid) and acetic acid is only
6%. It is clear that HI reacts with BaP probably via
release of 12 the probable attaching reagent.

*. Most recently analysis recovery of comparison of phosphorus
effects in reduction were extremely low, which were 4-6%
with phosphorus and 1% without phosphorus, probably due
to the loss from long period storing.
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5.3 Reductive Yield of Selected PAH Metabolites
With different PAH standard metabolites, the precedure
in Figure 12 was employed to observe the reduction yield of
these compounds. It is clear that recoveries of BaP
metabolites are extremely low while those of smaller PAH
such as pyrene and anthracene are much higher.

71

Table. 21

Reduction Yields of PAH metabolites

PAH Metabolites

Recoverya
With HI & HAc

3-hydroxy-BaP

0.3%

BaP-3,6-dione

0.2% or N.Db

BaP-4,5-dione

0.1%

BaP-7,8-dione

0.1%

BaP-6,12-dione

N.D.

9-Benzo(a)pyrenyl-b-dglucopyranosiduronic acid

N.D.

Pyrenec

120%

1-hydroxypyrene

85%

2-hydroxypyrene

65%

4-hydroxypyrene

92%

Pyrene-1,6-quinone

50%

Pyrene-1,8-quinone

25%

Anthraquinone
a.

110%

Recovery: BaP metabolites are recovered as BaP. Pyrene
metabolites are recovered as pyrene and anthraquinone
is recovered as anthracene.

b.

N.D. : Not Detected.

c.

The limit of detection for pyrene is 0.1 ng/m1=10 ng/13
Excitation: 335.5 nm. Emission: 390.0 nm.
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5.4 Improving the Reduction Yield with Red Phosphorus
Disappointed by the very poor recoveries of BaP (Fig. 12)
and its metabolites (Table 21), attempts were made to
increase the yield.
Following Gardon and Wolloam's procedure4, BaP metabolite
standard and [3H]BP treated mouse urine were reacted with
sodium borohydride in acidic media. However, the recovery
was still extremely low. The results of reduction with zinc
were unsuccessful also (Table 22).

Table 22. Recovery of 3-OH-BaP and BaP Metabolites In
Radio-labelled Mouse Urine By Reduction of
Sodium Borohydride or Zinc In Acidic Media
Reduction With NaBH4

Recovery

Recovery

3-OH-BaP:
Mouse Urine:

Reduction With Zinc

Not detected
1.6%

2%
--

The key to the Bjorseth procedure) is the reduction by
hydriodic acid which was based on the report of Konieczny
and Harvey5. In their experiments, Konieczny and Harvey
originally improved upon a procedure which involved
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phosphorus when they were successful omitting it and thus
allowing a cleaner procedure. However, they tested their
reaction on smaller ring systems and never reached the
pentacyclic PAH. The larger rings are more easily oxidized
and this is especially true for BaP. Thus, the procedure was
not an improvement for BaP and in fact lowered the yield.
Improvement was made by simply returning to the original
procedure (refluxing hydriodic acid with red phosphorus at
acid media, see Figure 14 ). The results show that this
change has a significantly increased the recovery of BaP and
BaP metabolites by 3-4 fold.

For the BaP standard, the results of refluxing with acetic
acid, hydriodic acid and red phosphorus (0.2g) is 3 time
that of without phosphorus( Table 23).
With [3H]BP treated mouse urine, the modified procedure
was tested. The recovery of BaP metabolites in mouse urine
are listed in Table 23 and comparison of recovery with and
without phosphorous is shown in Figure 10.
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Table. 23 Recovery of BaP Metabolites in Radio-labelled
Mouse Urine

WITHOUT PHOSPHOROUS

WITH PHOSPHOROUS

RESULTS

RECOVERY

RESULTS RECOVERY

42 ng/ml

2.1%

160 ng/ml

8%

43 ng/ml

2.2%

240 ng/ml

13%

Mouse Urine:

BaP Standard:
(70 ng/ml)

3-OH BaP:
(10 ugh].)

7 ng/ml

10%

22 ng/ml

32%

12 ng/ml

17%

23 ng/ml

33%

28 ng/ml

0.3%

150 ng/1

1.5%

Duplicate comparisons were made on collected human urine
samples to observe the function of phosphorus in the
reductive action( Fig. 16-18 and Table 24). The average
improvement of the overall recovery was a factor of 3-4
(Mean 3.8 ). It is clear that red phosphorus allows for
more quantitative reduction of BaP metabolites.
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Table 24. Summary of Comparison of The Effects of Red
Phosphorus in The Recovery of BaP Metabolites

Without
Phosphorus
(ug/l)

P/NPa Ratio

Sample I.D.

With
Phosphorus
(ug/l)

ID 42 D02

0.01

N.D.b

4.0

ID 42 DO5

0.11

0.05

2.2

ID 81 D03

0.05

N.D.

20.0

ID 81 D04

0.02

0.01

2.0

ID 81 D05

0.03

N.D.

12.0

ID 81 D06

0.06

0.03

2.0

ID 81 D07

0.04

N.D.

16.0

ID 81 D08

0.01

0.01

1.0

ID 81 D09

0.03

0.02

1.5

ID 81 D12

0.02

N.D.

8.0

ID 92 D07

0.02

0.006

3.3

ID 92 D08

0.06

0.02

3.0

ID 92 D09

0.04

0.01

4.0

ID 92 D10

0.03

N.D.

12.0

Mean: 6.50
S.D.: 5.88
a. P/NP - The ratio of analytical results with red
phosphorus and the results without red phosphorus.
b. N.D. - Not detected.
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FIGURE 8. THE RECOVERY OF BaP THROUGH CHROMATOGRAPHY STEP
SAMPLE (BaP STANDARD 70 ng/ml CYCLOHEXANE,
100 ul IN 50 ml WATER)
CONC. HYDROCHLORIC ACID 5 ml
30 min. pH=2
THROUGH SEP-PAK C18 CARTRIDGE
ELUTED WITH 5 ml METHANOL
5 ml CYCLOHEXANE
COMBINED SOLUTION POURED INTO
80 ml 1% POTASSIUM DISULFATE
EXTRACTION WITH CYCLOHEXANE TWICE
40 ml AND 20 ml
BLOW DOWN TO 1 ml WITH AIR.
SPOTTING 100 ul TO
ACETYLATED CELLULOSE PLATE
SCANNING WITH
FLUORESCENCE SPECTROPHOTOMETER

RECOVERY:
BaP STANDARD

30-40 % (n=2)
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FIGURE 9.

THE RECOVERY OF BaP AND 3-OH BaP
IN REFLUXING PROCEDURE

SAMPLE (BaP STANDARD 70 ng/ml, 100 ul
3-OH BaP
10 ug/ml,
1 mL)
10 ml GLACIAL ACETIC ACID
1 ml 49% HYDRIODIC ACID ( OR WITHOUT HYDRIODIC ACID )
REFLUXING 24 Hrs.
HOT SOLUTION POURED INTO
80 ml 1% POTASSIUM DISULFATE
EXTRACT WITH CYCLOHEXANE TWICE
(40 ml AND 20 ml)
BLOW DOWN TO 1 ml WITH AIR.
SPOTTING 100 ul TO
ACETYLATED CELLULOSE PLATE
SCANNING WITH
FLUORESCENCE SPECTROPHOTOMETER

RECOVERY
WITH HYDRIODIC ACID & ACETIC ACID
BaP

21 % - 31 % (n=2)

WITHOUT HYRIODIC ACID
BaP

80 % - 99 % (n=2)
NORMAL REFLUXING PROCEDURE

3-OH BaP

0.3 %
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FIGURE 10. THE RECOVERY OF BaP IN THE EXTRACTION PROCEDURE
SAMPLE (BaP STANDARD 70 ng/ml in CYCLOHEXANE,
100 ul IN 50 ml WATER)
SOLUTION POURED INTO
80 ml 1% POTASSIUM DISULFATE
EXTRACT WITH CYCLOHEXANE TWICE
(40 ml AND 20 ml)
BLOW DOWN TO 1 ml WITH AIR.
SPOTTING 100 ul TO
ACETYLATED CELLULOSE PLATE
SCANNING WITH
FLUORESCENCE SPECTROPHOTOMETER

RECOVERY: 80 % - 90 % (n=2)
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FIGURE 11. THE RECOVERY OF BaP IN THE STEP OF BLOW DOWN BY AIR

SAMPLE (BaP STANDARD 70ng/m1 in CYCLOHEXANE, 100u1)
60 ml CYCLOHEXANE
BLOW DOWN TO 1 ml WITH AIR.
SPOTTING 100 ul TO
ACETYLATED CELLULOSE PLATE
SCANNING WITH
FLUORESCENCE SPECTROPHOTOMETER

RECOVERY: 86 % - 107 % (n=2)
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FIGURE 12. SUMMARY OF THE RECOVERY OF BaP IN THE NORMAL
BECHER/BJORSETH PROCEDURE

SAMPLE (BaP STANDARD 70 ng/ml in CYCLOHEXANE_
100 ul IN 50m1 WATER)
CONC. HYDROCHLORIC ACID 5 ml
30 min.
> 30-40%

THROUGH SEP-PAK CARTRIGE
ELUTED WITH 5 ml METHANOL
5 ml CYCLOHEXANE
BLOW TO DRY WITH AIR

_

10 ml ACETIC ACID
1 ml 49% HYDRIODIC ACID
> 30-36 %
REFLUXING 24 Hrs.
HOT SOLOTION POUR INTO
80 ml 1% POTASSIUM DISULFATE

_
> >80 %

EXTRACTE WITH CYCLOHEXANE
40 ml AND 20 ml TWICE
BLOW DOWN TO 1 ml WITH AIR.
SPOTTING 100 ul TO
AC TYLATED CELLULOSE PLATE

»90 %

SCANNING WITH
FLUORESCENCE SPECTROPHOTOMETER

_

Total Estimated Recovery = 35% x 33% x 80% x 90% = 8%
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Figure 13. HPLC OF RADIO-LABELLED MOUSE URINE
(Courtesy of Dr. Regina Santella)

Z8

FIGURE 14. RECOVERIES OF 3-OH BaP AND MOUSE URINE IN NORMAL
PROCEDURE WITH RED PHOSPHORUS AND WITHOUT RED
PHOSPHORUS
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Figure 15. Com c are BaP In Vouse Urine
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With Phosphorus Modified Reduction

Figure 16. Compare Effect Of Phosphorus
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In The Reduction Of BaP Metabolites

Figure 17 Compare Effect Of Phosphorus
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In Recovery Of BaP Metabolites

Figure 18. Compare Effect Of Phosphorus
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In The Reduction Of BaP Metabolites
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CHAPTER 6 DISCUSSION AND CONCLUSIONS

6.1 Comparison of BaP Exposure to Urinary Excretion
The urinary BaP levels reported in this preliminary study
are consistent with values reported by other investigators
(See Chapter Two). BaP levels in the exposure and urine
samples are above detection and are highly variable ( >20fold) for the 11 non-smoking, non-occupationally exposed
participants. A positive association between the variables
may be emerging. (Fig. 7) With this preliminary and limited
data set, the predictive association bettween exposure and
elimination is tenuous. Conclusions about this data will
await further analyses of this data and the inclusion of
pending analyses.
The relationship of exposure to elimination will be
explained further by the inclusion of the remaining Phase
II data along with Phase III data. The Phase III data will
include a comparison of the Becher and Bjorseth method of
urine analyses with that of the method used by
Jongeneelen.1
Cigarette smoking is considered an important source of
PAH exposure. A smoker of filter cigarettes might inhale
0.4 ug benzo(a)pyrene per pack.2 This is reflected in a
significant increase in the excretion of PAH and PAH
metabolites in smokers' urines as compared to a non-smoking
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control group. Similar results were obtained by Repetto and
Martinez3 for benzo(a)pyrene and by Maly for
dibenzo(a,l)pyrene.4 From our results, it seems that a
positive relationship between smoking and excretion of BaP
and BaP metabolites may be inferred. However, with these
limited data derivation of a conclusion is premature.
6.2 Development of Analytical Protocol
The idea of using the reductive action of HI in the
Bjorseth and Becher method was derived from the Konieczny
and Harvey paper.5 These latter omitted phosphorus from
the hydriodic reagent. However, this modification was only
tested on PAH with less than four aromatic rings. Moreover,
in their summary the authors indicate that for resistant
cases(e.g. 1-hydroxynaphthalene and 9-hydroxyphenanthrene),
HI needed to be employed with red phosphorus. It is also
known that relative yields of reduction of different
aromatic compounds are anticipated to be a function of
energies to surmount the unfavorable keto-phenol equilibria
at each stage5 (Fig. 19). Thus, the yields may vary within
a given group of isomers.
As mentioned before, most carcinogenic PAH are larger than
tetracyclic(Fig. 1) and are transformed extensively in vivo.
With its five rings, BaP is more readly oxidized than its
benzenoid isomers as well as its smaller homologues.
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Fig.19 Protonation and Hydride Transfer from HI
with Formation of I and dehydration at
Each Stage
Source: ref. 5
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Hydrogen iodide dissociates at higher temperatures to
iodine and hydrogen, which effects hydrogenations. The
reaction is reversible. Its equilibrium is shifted in favor
of the decomposition by the reaction of hydrogen with
organic compounds to be reduced but it can also be affected
by removal of iodine; this can be accomplished by allowing
iodine to react with phosphorus to form phosphorus
triiodide which decomposes in the presence of water to
phosphorous acid and hydrogen iodide. In this way, by
adding phosphorus to the reaction mixture hydrogen iodide
is recycled and the reducing efficiency of hydriodic acid
is enhanced6

HI + Hydroxy-BaP ---> H2O + BaP + I2
P + H2O + I2

--->

H3PO4 + HI

In the Becher/Bjorseth procedure, iodine formed during
reflux may convert BaP to a mixture of quinones and
further oxidation destroys the aromatic nucleus7. Iodine may
also form complexes with BaP.8 The results of our study
support these assumptions.
The recovery of BaP standard refluxed with iodine is 4%;
with iodine and acetic acid it is 6%, with hydriodic acid
and acetic acid the recovery is 30%, while with acetic acid
alone recovery is 99%. For BaP metabolites, the Becher/
Bjorseth standard reduction procedure was very low in
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efficiency. In an attempt to improve recoveries, the chemical
preparation of the sample was modified to included red
phosphorus. Red phosphorus is believed to quench iodine's
reaction with the parent BaP. With this modification,
recoveries have approximately tripled. It is likely that with
appropriate modification of reactant ratios and experimental
conditions, the reduction may be controlled to afford the
most satisfictory recovery.
Another weakness of the Becher/Bjorseth procedure is the
loss from C18 cartridge chromatography. Our low recovery
(35%) for this step is in line with the Becher/Bjorseth
report (40%)9. Tests will be made to find a more efficient
extraction method.
The low hydrolysis yield will be improved by substituting
enzyme hydrolysis for chemical hydrolysis.

6.3 Investigation of Pyrene Metabolites as a Biomarker
The rational for development of pyrene metabolites as a
biomarker of human exposure was introduced in Chapter 2.
Three reasons to select pyrene as a biomarker of PAH air
pollutant are:
a. Pyrene is less reactive than BaP in air. Pyrene is
oxidized with greater difficulty.
b. In the atmosphere, the pyrene concentration is higher
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than that of BaP.1
c. Pyrene metabolizes almost exclusively to 1-hydroxypyrene
in contrast with the more than twenty kinds of metabolites
obtained from BaP.
Pyrene and its metabolites had acceptable recoveries in
the procedure employed. However, we failed to detect pyrene
and its metabolites in human urine, probably dueto
difficulties in chromatographic separation. The possibility
of using pyrene metabolites as a surrogate for PAH
metabolites will be investigated in futher studies.
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